news

Vigor Boost Gummies Claims Evaluated: The ForceVital Male Enhancement Formula Under Investigation

Largo, FL, April 18, 2026 (GLOBE NEWSWIRE) -- This release provides an informational summary of Vigor Boost Gummies based on…

4 weeks ago

SlimLeaf Claims Evaluated: The FitBurn Formula Using Slim Leaf Ingredients for Weight Loss

Largo, FL, April 18, 2026 (GLOBE NEWSWIRE) -- This report contains affiliate links. If a purchase is made through these…

4 weeks ago

BREAKTHROUGH PRIZE ANNOUNCES 2026 LAUREATES

Six $3 Million Prizes Awarded for Outstanding Discoveries in Life Sciences, Fundamental Physics and MathematicsGene Therapies for Inherited Blindness, Sickle…

4 weeks ago

Other World Computing (OWC) Launches MacDrive 12 at NAB 2026 One Solution for Complete Mac Disk Access on Windows – Including Native Encrypted APFS Support

WOODSTOCK, Ill., April 18, 2026 (GLOBE NEWSWIRE) -- WOODSTOCK, Ill. and LAS VEGAS (April 18, 2026) Other World Computing (OWC®),…

4 weeks ago

Other World Computing Launches OWC Express 4M2 Ultra at NAB 2026 Thunderbolt 5 Four-Slot NVMe M.2 SSD Enclosure

Built for Professionals Seeking the Fastest DIY RAID Performance in a Compact Design – To Be Showcased Live for the…

4 weeks ago

Tradull Develops Structured Framework to Improve Visibility in Commodity Trade Processes

NEW YORK, April 18, 2026 (GLOBE NEWSWIRE) -- Tradull has introduced a structured framework aimed at improving visibility and organization…

4 weeks ago

2025 China & Global Development Reports Published in Hainan

HAIKOU, China, April 18, 2026 /PRNewswire/ -- A report from the Hainan International Media Center: In Haikou on April 16th, during…

4 weeks ago

Shanghai’s INS LAND Crowned China’s Best Club in DJ Mag’s Top 100, Ranks #3 in Asia and #12 Worldwide

SHANGHAI, April 15, 2026 /PRNewswire/ -- INS Land, a multi-story nightlife and entertainment complex in the heart of Shanghai, ranks…

4 weeks ago

Press Release: ESCMID: Sanofi’s Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study

ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study First head-to-head, double-blind, randomized phase 4 study…

4 weeks ago

VigoSurge Claims Evaluated: Analyzing the Ingredients’ Benefits, Side Effects Risk and Customer Complaints

Aurora, CO, April 18, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This release is for informational purposes only and does not constitute…

4 weeks ago